Rwanda-Oman: Agreement on the production of medicines

Rwandan pharmaceutical companies, Rwanda Medical Supply Ltd (RMS) and Labophar have signed a long-term agreement with Omani pharmaceutical company, Philex Pharmaceuticals, to expand access and local production of medicines.

This agreement signed in Doha, Qatar, between Philex Pharmaceuticals and Rwanda Medical Supply aims to expand access to essential medicines in Rwanda, particularly those intended for oncology and cardiology treatments.

Rwanda was represented by Diana Mutoni, Deputy Managing Director of Rwanda Medical Supply, and Pascal Gatete, Director of Labophar. The Omani company, Philex Pharmaceuticals, was represented by its Director, Waseem Hamad. Rwandan Ambassador to Qatar, Igor Marara, was present at the ceremonies.

Rwanda Medical Supply Ltd is a state-owned company dedicated to ensuring the consistent availability of essential medical supplies throughout Rwanda. The company provides comprehensive supply chain management, ensuring healthcare providers have the resources they need to deliver quality care to the Rwandan population.

Philex Pharmaceuticals has signed a joint venture and technology transfer agreement with Rwandan company Labophar Ltd.

In a related agreement, Omani company Philex Pharmaceuticals also signed a joint venture and technology transfer agreement with Rwandan company Labophar Ltd.

This agreement will enable Labophar to locally manufacture Philex’s solid pharmaceutical forms, thereby strengthening Rwanda’s capacity to produce high-quality medicines on its territory.

LABOPHAR Ltd is a Rwandan company that has been manufacturing pharmaceutical products since 1983. Its mission is to provide high-quality medicines at affordable prices in Rwanda and Africa.

Philex is committed to manufacturing and packaging high-quality pharmaceutical and biopharmaceutical products.

Philex Pharmaceuticals is a multinational pharmaceutical company headquartered in the Sultanate of Oman, in the Salalah Free Zone. The company is currently investing in the Qatar Pharmaceutical Complex. Using the latest manufacturing technologies and multinational partnerships, Philex is committed to manufacturing and packaging high-quality pharmaceutical and biopharmaceutical products.